Geetika Dhanda

95 posts

Geetika Dhanda

Geetika Dhanda

@DhandaGeetika

Postdoctoral researcher @broadinstitute| PhD @JNCASR| Infectious Diseases, Drug design, Chemical Biology.

Boston, MA Katılım Temmuz 2019
632 Takip Edilen297 Takipçiler
Geetika Dhanda
Geetika Dhanda@DhandaGeetika·
A part of my PhD research has been published in @ACSCentSci. The article describes the streamlined development of a dual-functional antibiotic adjuvant which shows potency against complicated Gram-negative bacterial infections and exhibits promising immunomodulatory properties.
Jayanta Haldar@jayanta_amr

Happy to share our latest paper, published in @ACSCentSci. We report a novel dual-functional antibiotic adjuvant, with potency against challenging Gram-negative superbugs, along with promising immunomodulatory property. Congratulations to all the authors! pubs.acs.org/doi/full/10.10…

English
0
2
23
879
Geetika Dhanda retweetledi
DWeissLab
DWeissLab@DWeissLab·
Bactericidal antibiotics release DNA that activates TLR9, while static antibiotics do not. Can profoundly impact treatment outcome. Should clinicians consider this when choosing antibiotics? Amazing work by Julia Gross and collaboration with Iain Fraser! nature.com/articles/s4146…
English
2
25
94
7.6K
Geetika Dhanda retweetledi
nature
nature@Nature·
The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers go.nature.com/3Tb1PMf
English
11
148
480
109K
Geetika Dhanda retweetledi
David R. Liu
David R. Liu@davidrliu·
In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK. “A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for patients aged 12 and over after a rigorous assessment of its safety, quality and effectiveness.” Congratulations to the many scientists, doctors, patients, and industry leaders who made this development possible.🍻 gov.uk/government/new…
English
21
308
1.4K
189.1K
Geetika Dhanda
Geetika Dhanda@DhandaGeetika·
@ShivarSimbu Hi. Antibiotic adjuvants are either completely non-active (MIC > 512 ug/mL) or they show minimal activity (MIC ~ 64 ug/mL). However, at subinhibitory concentrations, these compounds potentiate antibiotics.
English
1
0
1
24
Bram31
Bram31@ShivarSimbu·
@DhandaGeetika Hi.. I read.your paper on antibiotic adjuvants. Could you maybe suggest a range based on MIC for a molecule to be considered an "adjuvant"
English
1
0
0
18
Nandita Dhanda
Nandita Dhanda@nanditadhandaaa·
A little late in posting but, I am thrilled to announce that earlier last month I started my PhD at @unige_en with @ignaziano! can’t quite believe I get to spend the next few years asking very exciting questions and call Geneva home!
Nandita Dhanda tweet mediaNandita Dhanda tweet media
English
6
0
19
1.7K
Raagya Arora
Raagya Arora@AroraRaagya·
Today I poured my heart into defending my thesis. The overwhelming sense of gratitude is indescribable! Just 2 days after my twin did the same – sharing this incredible achievement doubling the joy! @pragyaarora26 Standing at the bridge b/w theory and experiment at @Harvard #phd
Raagya Arora tweet media
English
35
10
725
72.9K
Vishal Lolam
Vishal Lolam@VishalLolam·
Extremely thankful to the Indian academy of Neuroscience committee for considering my application and giving me an opportunity to present my work. Thank you @roy_achira for your guidance and support.
Achira Roy@roy_achira

Another #labfirsts: Heartiest congratulations to @VishalLolam @jncasr for receiving Travel Award to present his work at the XLI Annual Meeting of IAN and International Conference on "Brain: Chemistry to Cognition", Gwalior. Am excited to see you walk steady steps ahead...

English
3
0
15
977
Biswas Lab
Biswas Lab@BiswasLabJNC·
📢🚨HERE WE GO !! Congratulations to @DebattamS on successfully defending his Ph.D. work. 🥳🥳🥳🥳🥳🍻 All the best for your future endeavors . @kanishkabiswas #PhD @jncasr
Biswas Lab tweet media
English
13
5
140
5.3K
Geetika Dhanda retweetledi
Ankit Jain
Ankit Jain@ajabsurd·
Happy to share that, starting this fall, I will be joining @bklyncollege411 @CUNY as an asst. prof.! I will be heading @syschemlab and look forward to working on various aspects of systems chemistry. A special thank you to @Ulijngroup, @SubiJGeorge, Bert Meijer, and @pkvemula!
Systems Chemistry Lab@syschemlab

The systems chemistry lab will be up and running this fall @bklyncollege411 @CUNY! We hope to work on finding systems chemistry solutions to proto-cellular life, novel therapeutics, and everything in between. For opportunities: syschemlab.com/opportunities. RT appreciated.

English
30
12
108
16.1K
Geetika Dhanda retweetledi
C-CAMP
C-CAMP@CCAMP_India·
7 days left! Turn your ideas into reality with the Biotechnology Ignition Grant (BIG)! Tap into follow-on funding opportunities over 8 crores INR ($1M) by partnering with CCAMP Write to ccamp_big@ccamp.res.in 🌐ccamp.res.in/seed-funding-b… @Taslimarif @Birac_2012
C-CAMP tweet media
English
1
3
6
613
Geetika Dhanda retweetledi
Trends in Microbiology
Trends in Microbiology@TrendsMicrobiol·
Out online now: Review on Enterococci facilitating polymicrobial infections dlvr.it/StKzpy
English
0
14
41
5.3K
Geetika Dhanda retweetledi
C-CAMP
C-CAMP@CCAMP_India·
Biotech Ignition Grant #BIG is the starting point for your entrepreneurial success in Lifesciences Many CCAMP partnered BIG companies have gone on to create a bigger impact with follow-on fundings & commercial success For the BIG 23rd call, partner with CCAMP Just 8 more days! Apply soon Email: ccamp_big[at]ccamp.res. in @BIRAC_2012 @DBTIndia @Taslimarif
C-CAMP tweet media
English
0
8
18
1.7K